Last reviewed · How we verify

Prevention of COVID-19 in individuals 6 months of age and older

8 treatments

Approved treatments

Clinical guidelines

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Prevention of COVID-19 in individuals 6 months of age and older

What drugs treat Prevention of COVID-19 in individuals 6 months of age and older?

Tracked treatments include Comirnaty, Covid-19 Sterilizing, Tozinameran 6 months to 4 years of age, Pfizer-BioNTech COVID-19 mRNA vaccine, BNT162b2 (Omi XBB.1.5)/RIV, Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose, BNT162b2 (Omi XBB.1.5).

What is the treatment for Prevention of COVID-19 in individuals 6 months of age and older?

Standard treatment for Prevention of COVID-19 in individuals 6 months of age and older includes Comirnaty, Covid-19 Sterilizing, Tozinameran 6 months to 4 years of age, Pfizer-BioNTech COVID-19 mRNA vaccine, BNT162b2 (Omi XBB.1.5)/RIV. See the treatment landscape page for first-line, second-line and salvage options.

What are the treatment guidelines for Prevention of COVID-19 in individuals 6 months of age and older?

FDA label publishes guidelines for Prevention of COVID-19 in individuals 6 months of age and older. 3 guideline references tracked.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing